Works matching IS 13889842 AND DT 2022 AND VI 24 AND IP 3
Results: 29
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
Prevention is better than cure: modifiable risk factors for heart failure better understood.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 481, doi. 10.1002/ejhf.2448
- Publication type:
- Article
Drug therapy for heart failure with reduced ejection fraction: what is the 'right' dose?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 421, doi. 10.1002/ejhf.2447
- By:
- Publication type:
- Article
A Heart Team approach to contemporary device decision‐making in heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 562, doi. 10.1002/ejhf.2445
- By:
- Publication type:
- Article
Dapagliflozin effect on heart failure with prevalent or new‐onset atrial fibrillation.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 526, doi. 10.1002/ejhf.2443
- By:
- Publication type:
- Article
The fastest way to the heart is through the veins: towards a better understanding of congestion.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 463, doi. 10.1002/ejhf.2442
- By:
- Publication type:
- Article
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 548, doi. 10.1002/ejhf.2441
- By:
- Publication type:
- Article
Diabesity and heart failure with preserved ejection fraction: the picture is getting clearer.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 510, doi. 10.1002/ejhf.2440
- By:
- Publication type:
- Article
Left atrial function: the HbA1c for the cardiologist and even more.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 494, doi. 10.1002/ejhf.2438
- By:
- Publication type:
- Article
The AMULET ménage à trois: nurse, telemedicine support, and remote cardiologist.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 578, doi. 10.1002/ejhf.2437
- By:
- Publication type:
- Article
Dapagliflozin post‐transcatheter aortic valve implantation: the need for further evidence.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 589, doi. 10.1002/ejhf.2436
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
- By:
- Publication type:
- Article
Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A population‐based study of 92 clinically recognized risk factors for heart failure: co‐occurrence, prognosis and preventive potential.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 466, doi. 10.1002/ejhf.2417
- By:
- Publication type:
- Article
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 406, doi. 10.1002/ejhf.2414
- By:
- Publication type:
- Article
Measures of left atrial function predict incident heart failure in a low‐risk general population: the Copenhagen City Heart Study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 483, doi. 10.1002/ejhf.2406
- By:
- Publication type:
- Article
Corrigendum to 'Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials' [Eur J Heart Fail 2020;11:2160–2171].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 591, doi. 10.1002/ejhf.2404
- Publication type:
- Article
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 497, doi. 10.1002/ejhf.2403
- By:
- Publication type:
- Article
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 442, doi. 10.1002/ejhf.2398
- By:
- Publication type:
- Article
Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 431, doi. 10.1002/ejhf.2397
- By:
- Publication type:
- Article
Corrigendum to 'Iron deficiency and risk of early readmission following a hospitalization for acute heart failure' [Eur J Heart Fail 2016;18:880-880].
- Published in:
- 2022
- Publication type:
- corrected article
Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 455, doi. 10.1002/ejhf.2395
- By:
- Publication type:
- Article
Corrigendum to 'High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality' [Eur J Heart Fail 2021;23:919–932].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 591, doi. 10.1002/ejhf.2383
- Publication type:
- Article
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
- By:
- Publication type:
- Article
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 581, doi. 10.1002/ejhf.2370
- By:
- Publication type:
- Article
Effects of an outpatient intervention comprising nurse‐led non‐invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart failure (AMULET study): a randomised controlled trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 565, doi. 10.1002/ejhf.2358
- By:
- Publication type:
- Article
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS‐HF and RALES.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 529, doi. 10.1002/ejhf.2350
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
March 2022 at a glance: focus on medical therapy, prevention and comorbidities.
- Published in:
- 2022
- By:
- Publication type:
- journal article